참고문헌
- Badie B, Goh CS, Klaver J, Herweijer H, Boothman DA : Combined radiation and p53 gene therapy of malignant glioma cells. Cancer Gene Ther 6 : 155-162, 1999 https://doi.org/10.1038/sj.cgt.7700009
- Black PM : Brain tumor. part 2. N Engl J Med 324 : 1555-1564, 1991 https://doi.org/10.1056/NEJM199105303242205
- Chung HT, Kim JE, Kim DG, Jung HW : A stereotactic device for gamma knife irradiation to cell lines. J Korean Neurosurg Soc 35 : 639-642, 2004
- Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Tayler DL, et al : In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55 : 1-6, 1995
- El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al : WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54 : 1169-1174, 1994
- El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al : WAF1, a potential mediator of p53 tumor suppression. Cell 75 : 817-825, 1993 https://doi.org/10.1016/0092-8674(93)90500-P
- Frankel RH, Bayona W, Koslow M, Newcomb EW : p53 mutations in human malignant gliomas : comparison of loss of heterozygosity with mutation frequency. Cancer Res 52 : 1427-1433, 1992
- Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, et al : Adenovirus-mediated transfer of the p53 gene products rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56 : 694-699, 1996
- Gotz C, Montenrh M : p53 : DNA damage, DNA repair, and apoptosis. Rev Physiol Biochem Pharmacol 127 : 65-95, 1995 https://doi.org/10.1007/BFb0048265
- Haupt Y, Rowan S, Oren M : p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10 : 1563-1571, 1997
- Kim JE, Paek SH, Chung HT, Kim DG, Jung HW : in vitro biological response of malignant glioma cell lines to gamma knife irradiation. J Korean Neurosurg Soc 35 : 599-604, 2004
- Kim SK, Wang KC, Cho BK, Chung HT, Kim YY, Lim SY, et al : Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines. J Neurosurg 97 : 143-150, 2002 https://doi.org/10.3171/jns.2002.97.1.0143
- Kock H, Harris MP, Anderson SC, Machemer T, Hancock W, Sutjipto S, et al : Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer 67 : 805- 815, 1996 https://doi.org/10.1002/(SICI)1097-0215(19960917)67:6<808::AID-IJC9>3.0.CO;2-V
- Levine AJ, Momand J, Finlay CA : The p53 tumour suppressor gene. Nature 351 : 453-456, 1991 https://doi.org/10.1038/351453a0
- Li H, Lochmuller H, Yong VW, Karpati G, Nalbantoglu J : Adenovirusmediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status. J Neuropathol Exp Neurol 56 : 872-878, 1997 https://doi.org/10.1097/00005072-199708000-00005
- Lowe SW, Ruley HE, Jacks T, Housman DE : p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 : 957-967, 1993 https://doi.org/10.1016/0092-8674(93)90719-7
- Mcllwrath AJ, Vasey PA, Ross GM, Brown R : Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54 : 3718-3722, 1994
- Miyashita T, Reed JC : Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 : 293-299, 1995 https://doi.org/10.1016/0092-8674(95)90412-3
- Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, et al : Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15 : 3032-3040, 1995 https://doi.org/10.1128/MCB.15.6.3032
- Polednak AP, Flannery JT : Brain, other central nervous system, and eye cancer. Cancer 75(Suppl 1) : 330-337, 1995 https://doi.org/10.1002/1097-0142(19950101)75:1+<330::AID-CNCR2820751315>3.0.CO;2-5
- Putzer BM, Bramson JL, Addison CL, Hitt M, Siegel PM, Muller WJ, et al : Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum Gene Ther 9 : 707-718, 1998 https://doi.org/10.1089/hum.1998.9.5-707
- Raycroft L, Wu HY, Lozano G : Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249 : 1049-1051, 1990 https://doi.org/10.1126/science.2144364
- Salcman M : Surgical resection of malignant brain tumors : who benefits? Oncology 32 : 931-941, 1988
- Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB : Loss of a p53- associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53 : 4164-4168, 1993
- Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr : Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene 10 : 1053-1059, 1995
- von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, et al : p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52 : 2987-2990, 1992
- Wara WM, Bauman GS, Sneed PK : Brain, brain stem and cerebellum, in Perez CA, Brady LW (eds) : Principles and Practice of Radiation Oncology. Philadelphia : Lippincott-Raven, 1998, pp777-828